The ResQ Biotech Team
Who We Are
%20(.jpg)
GEORGIOS SKRETAS
Chief Executive Officer & Chief Scientific Officer
Georgios Skretas received his Bachelor's degree from the School of Chemical Engineering, National Technical University of Athens (Greece) in 1998 and his PhD in Chemical and Biological Engineering from Princeton University (USA) in 2006. He then worked as a post-doctoral research associate at the Institute
of Cell and Molecular Biology of the University of Texas at Austin (USA) (2006-2009). In 2010, he received a Marie Curie International Reintegration Fellowship to return to Greece and the National
Hellenic Research Foundation (NHRF). Since then, he has been Principal Investigator of the Laboratory of Enzyme and Synthetic Biotechnology of the Institute of Chemical Biology at the NHRF, where he currently holds the rank of Research Associate Professor. Georgios Skretas has recently been awarded the highly prestigious Consolidator Grant by the European Research Council (ERC). He has published the results of his research in highly prestigious scientific journals, such as Nature Biomedical Engineering, Science Advances, Journal of the American Chemical Society and ACS Synthetic Biology, and he is inventor on four (4) patents/patent applications. He is the elected representative of Greece to the Scientific Committee of the European Section of Applied Biocatalysis.
KATERINA PAPANIKOLOPOULOU
ATHINA OIKONOMIDOU
Athina Oikonomidou holds a BSc degree in Chemical Engineering from the Aristotle University of Thessaloniki (1993) and a MBA from IESE (Un. Navarra, Barcelona, 1997). For the past 18 years she has been involved in Business Development and Technology Transfer specializing in Life Sciences and Biotechnology. She has collaborated with most Research Centers in the country, individual Researchers and Businesses. During this time she has overseen the preparation of dozens of Business Plans, has authored over 10 Feasibility Studies, Financial Sustainability Analyzes as well as Market and Commercial Development Studies. She also participates in teams conducting Patent Assessments. Athina has been the Director of Technology Transfer and Administrative Services of BSRC "Al. Fleming ”, where she oversaw the creation of the Center's intellectual property portfolio and co-ordinated the commercialization of the technologies and materials developed there. She has also worked with EkinisiLAB, the incubator of BSE companies, where he supported 23 teams in developing their Business Model and developing their Business Plan. She is an evaluator in the EU Horizon2020 SME Instrument Program where she has evaluated over 300 proposals. Athina teaches courses on "Introduction to Technology Transfer" and "Models of Commercialization in Life Sciences" in various postgraduate programs.
Chief Operating Officer
Chief R&D Officer
Katerina Papanikolopoulou is a neurobiologist specializing in protein misfolding diseases, with a focus on Tau-related neurodegenerative disorders. She received her B.Sc. in Chemistry from the University of Athens (2000) and her Ph.D. in Structural Biology from Université Joseph Fourier in Grenoble (2004), where she studied protein folding and amyloid aggregation at the Institut de Biologie Structurale. She then conducted postdoctoral research at the University of Crete, MIT, and BSRC "Alexander Fleming." In 2017, she was supported by the Stavros Niarchos Foundation and became a Group Leader at BSRC "Alexander Fleming". Dr. Papanikolopoulou has received competitive research grants, published extensively in high-impact journals, and actively collaborates on translational strategies for neurodegenerative disease therapeutics. In 2023, she joined ResQ Biotech as Chief R&D Officer.